“Results from Part 1 Safety Run-in Period of a 2-Part, Phase 2, Multicenter, Open-Label, Proof-of-Concept Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of VP-315 in Subjects With Basal Cell Carcinoma”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s260. Accessed April 14, 2025. https://skin.dermsquared.com/skin/article/view/2333.